Skip to main content

Lung cancer: new treatment approved for NSCLC

Patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who also carry the G12C mutation in the KRAS gene now have the option of newly approved sotorasib.
9/15/2021

Register for free access or login.

Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.

Membership is free and allows doctors, pharmacists, nurses and many others to get the latest breaking news, updates on clinical guidelines and read (and even write) commentary from your healthcare peers.

X
This ad will auto-close in 10 seconds